{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-034857","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-08-28T21:00:55+00:00","discovered_at":"2026-08-28T21:02:01.824194+00:00","generated_at":"2026-08-28T21:02:14.479630+00:00","sec_items":["5.07","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Crinetics shareholders approve Vertex merger; closing expected Sept 1, 2026","bullets":["Merger adoption approved: 79,240,098 for, 13,618 against, 10,915 abstain.","Quorum of 74.71% (79,264,631 of 106,095,205 shares) represented at special meeting.","Non-binding advisory compensation proposal rejected: 33,854,149 for, 44,803,403 against.","Advisory vote failure not a condition; final closing condition now satisfied.","Closing of Vertex acquisition expected on or about September 1, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-034857","json":"https://secwatch.observer/filing/0001140361-26-034857.json","markdown":"https://secwatch.observer/filing/0001140361-26-034857.md","text":"https://secwatch.observer/filing/0001140361-26-034857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126034857/0001140361-26-034857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126034857/ef20080970_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T21:02:14.479630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}